Bank of America’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-97,105
| Closed | -$1.83M | – | 7709 |
|
|
2019
Q3 | $1.83M | Sell |
97,105
-138,144
| -59% | -$1.58M | ﹤0.01% | 4129 |
|
|
2019
Q2 | $2.77M | Sell |
235,249
-23,404
| -9% | -$283K | ﹤0.01% | 3763 |
|
|
2019
Q1 | $3.53M | Buy |
258,653
+239,005
| +1,216% | +$3.1M | ﹤0.01% | 3494 |
|
|
2018
Q4 | $201K | Buy |
19,648
+8,252
| +72% | +$106K | ﹤0.01% | 5508 |
|
|
2018
Q3 | $189K | Sell |
11,396
-521,247
| -98% | -$9.42M | ﹤0.01% | 5517 |
|
|
2018
Q2 | $8.41M | Sell |
532,643
-21,819
| -4% | -$332K | ﹤0.01% | 2633 |
|
|
2018
Q1 | $7.04M | Buy |
554,462
+428,854
| +341% | +$6.2M | ﹤0.01% | 2748 |
|
|
2017
Q4 | $1.44M | Buy |
125,608
+8,641
| +7% | +$96.5K | ﹤0.01% | 4227 |
|
|
2017
Q3 | $1.43M | Sell |
116,967
-4,118
| -3% | -$42.9K | ﹤0.01% | 4255 |
|
|
2017
Q2 | $1.39M | Sell |
121,085
-62,432
| -34% | -$1.15M | ﹤0.01% | 4199 |
|
|
2017
Q1 | $3.82M | Buy |
183,517
+28,999
| +19% | +$642K | ﹤0.01% | 3289 |
|
|
2016
Q4 | $3.21M | Buy |
154,518
+1,717
| +1% | +$44.6K | ﹤0.01% | 3353 |
|
|
2016
Q3 | $5.01M | Sell |
152,801
-4,150
| -3% | -$126K | ﹤0.01% | 2830 |
|
|
2016
Q2 | $3.92M | Buy |
156,951
+37,722
| +32% | +$1.02M | ﹤0.01% | 3009 |
|
|
2016
Q1 | $2.92M | Sell |
119,229
-3,031
| -2% | -$70.2K | ﹤0.01% | 3247 |
|
|
2015
Q4 | $4.04M | Buy |
122,260
+10,224
| +9% | +$346K | ﹤0.01% | 3161 |
|
|
2015
Q3 | $3.67M | Buy |
112,036
+99,615
| +802% | +$4.24M | ﹤0.01% | 3193 |
|
|
2015
Q2 | $658K | Buy |
12,421
+12,388
| +37,539% | +$451K | ﹤0.01% | 4481 |
|
|
2015
Q1 | $1K | Sell |
33
-567
| -95% | -$15.6K | ﹤0.01% | 6912 |
|
|
2014
Q4 | $17K | Sell |
600
-3,800
| -86% | -$68.2K | ﹤0.01% | 6863 |
|
|
2014
Q3 | $56K | Buy |
+4,400
| New | +$66.5K | ﹤0.01% | 6430 |
|
Bank of America's ALDR Position: Q4 2019 in Review
Bank of America sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 97,105 shares — an estimated $1.83M sold.
Bank of America first reported a position in ALDR in Q3 2014 and held it in 21 quarters. The position peaked at $8.41M in Q2 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Bank of America reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 97,105 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.83M.
- Bank of America first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 21 quarters.
- Bank of America's Alder Biopharmaceuticals position peaked at $8.41M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.